MetLife, Inc.

New York Stock Exchange
Back to all articles
Somewhat Bullish +45

Bank of New York Mellon Corp Lowers Holdings in MetLife, Inc. $MET

AI-generated analysis

📉 Bank of New York Mellon Corp reduced its MetLife holdings by 25.8% in Q1, selling 1,241,561 shares while retaining a $253 million position.

📈 Vanguard Group increased its stake by 12.1% in Q4, adding 7,805,814 shares valued at approximately $5.7 billion.

📈 Pzena Investment Management LLC raised its position by 22.9% in Q4 to own 11,883,338 shares worth roughly $938 million.

📈 AQR Capital Management and Man Group plc also significantly increased their MetLife positions during the third and second quarters respectively.

💰 MetLife announced a quarterly dividend of $0.5925 per share with an ex-dividend date of August 4th, offering a 2.5% yield.

📊 The stock trades at a P/E ratio of 18.21 and has a market cap of $60.48 billion as of the latest trading session.

🏦 UBS Group raised its price target to $105.00 with a 'buy' rating, while Jefferies Financial Group set a $103.00 objective.

📉 Wall Street Zen downgraded MetLife from 'buy' to 'hold', though the average analyst consensus remains a 'Moderate Buy'.

Bullish Signals
  • Major institutional investors like Vanguard, Pzena, and AQR have increased their stakes in MetLife during recent quarters, indicating continued confidence in the company's long-term prospects.
  • MetLife maintains a solid dividend yield of 2.5% with a payout ratio of 45.93%, providing consistent income to shareholders.
  • Multiple brokerages including UBS and Jefferies have issued 'buy' ratings and raised price targets above the current trading price.
  • The company holds a strong market position as a global provider of life insurance, annuities, and employee benefit programs.
Risk Factors
  • Bank of New York Mellon Corp significantly reduced its holdings by over 25% in Q1, signaling a lack of confidence from at least one major institutional investor.
  • Wall Street Zen downgraded the stock from 'buy' to 'hold', reflecting some divergence in analyst sentiment regarding the company's valuation or outlook.
Full Analysis
Bank of New York Mellon Corp reduced its stake in MetLife, Inc. (NYSE:MET) by 25.8% during the first quarter, selling over 1.24 million shares to hold a remaining position valued at approximately $253 million. Conversely, several other major institutional investors increased their holdings significantly in the fourth and third quarters, including Vanguard Group, which added roughly 7.8 million shares worth nearly $5.7 billion, and Pzena Investment Management, which boosted its position by 22.9%. MetLife's stock recently opened at $93.99 with a market capitalization of $60.48 billion. The company maintains a dividend yield of 2.5%, set to pay $0.5925 per share on September 8th for shareholders of record on August 4th. Analyst sentiment remains generally positive, with an average target price of $98.57 and a consensus rating of 'Moderate Buy' from Wall Street firms like UBS and Jefferies. MetLife operates as a global provider of insurance, annuities, and employee benefit programs headquartered in New York City. Its core business segments include life insurance, group benefits, retirement products such as annuities, and supplemental health coverage including dental and disability plans distributed through employer-sponsored programs.